Advanced search
Publication Cover
Journal of Substance Misuse Volume 3, 1998 - Issue 2
Journal homepage
35
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Drug use in South Wales: who uses Ecstasy anyway?

C. Handy Cardiff Community Drugs Team, 46 Cowbridge Road East, Canton, Cardiff, UK, CFI 9DU
,
R. Pates Cardiff Community Drugs Team, 46 Cowbridge Road East, Canton, Cardiff, UK, CFI 9DU
&
A. Barrowcliff Cardiff Community Drugs Team, 46 Cowbridge Road East, Canton, Cardiff, UK, CFI 9DU
Pages 82-88 | Accepted 16 Sep 1997, Published online: 12 Jul 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Patrick McCrystal & Andrew Percy. (2010) Factors associated with teenage ecstasy use. Drugs: Education, Prevention and Policy 17:5, pages 507-527.
Read now
Andrew Golub, Bruce D. Johnson, Stephen J. Sifaneck, Benjamin Chesluk & Howard Parker. (2001) IS THE U.S. EXPERIENCING AN INCIPIENT EPIDEMIC OF HALLUCINOGEN USE?. Substance Use & Misuse 36:12, pages 1699-1729.
Read now
H. Klee. (2001) Amphetamine use: crystal gazing into the new millennium: Part Two - alternative paths. Journal of Substance Use 6:2, pages 80-95.
Read now

Articles from other publishers (5)

Judith Aldridge. (2008) Decline but no fall?. Health Education 108:3, pages 189-206.
Crossref
Nicholas Seivewright, Charles McMahon & Paul Egleston. (2018) Stimulant use still going strong. Advances in Psychiatric Treatment 11:4, pages 262-269.
Crossref
Madeline Naegle. (2002) Addiction: A global public health challenge for nurses. Drugs and Alcohol Today 2:3, pages 11-22.
Crossref
LINDA R. GOWING, SUSAN M. HENRY‐EDWARDS, RODNEY J. IRVINE & ROBERT L. ALI. (2009) The health effects of ecstasy: a literature review. Drug and Alcohol Review 21:1, pages 53-63.
Crossref
Dorthe Hansen, Bruce Maycock & Tony Lower. (2001) ‘Weddings, parties, anything…’, a qualitative analysis of ecstasy use in Perth, Western Australia. International Journal of Drug Policy 12:2, pages 181-199.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.